Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001104659-18-000890

Options or other derivatives

  • Director acquired 8,267 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BLECH ISAAC · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-12-31 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +8,267 $3.20 2027-12-30 8,267 8,267 D
Loading xslF345X03/a4.xml…